ADMA
Adma Biologics Inc
$8.46
-1.17% ($0.10)
Volume
3.34M
52W High
$22.37
52W Low
$7.21
Market Cap
$2.38B
Next Earnings Report
Last Reported
May 7, 2026 Missed
Actual: $0.17
vs. Consensus: $0.20
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
-3.54%
5-Day:
-0.71%
Q1 2026
May 6, 2026
1-Day:
-15.97%
5-Day:
-21.83%
Q1 2026
Mar 31, 2026
1-Day:
+1.11%
Q4 2025
Mar 19, 2026
1-Day:
-4.66%
5-Day:
-24.57%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $139.2M | +18.4% | 63.8% | 45.1% | $49.4M |
| Q3'25 | $134.2M | +12.0% | 56.3% | 38.0% | $36.4M |
| Q2'25 | $122.0M | +13.8% | 55.1% | 35.1% | $34.2M |
| Q1'25 | $114.8M | +40.2% | 53.2% | 30.4% | $26.9M |
| Q4'24 | $117.5M | +59.1% | 53.9% | 32.6% | $111.9M |
| Q3'24 | $119.8M | +78.1% | 49.8% | 33.1% | $35.9M |
| Q2'24 | $107.2M | +78.3% | 53.6% | 36.6% | $32.1M |
| Q1'24 | $81.9M | +43.9% | 47.8% | 26.7% | $17.8M |
Company Information
Symbol
ADMA
Company
Adma Biologics Inc
Market Cap
$2.38B